German Christopher Paul's Form 4 filing
Rhythm Pharmaceuticals, Inc. (RYTM) · filed May 19, 2026
- Accession no.
- 0001104659-26-063830
- Filed
- May 19, 2026
- Trade date
- May 15, 2026
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 4 non-derivative transactions and 3 derivative transactions. Open-market sales total $428.1K. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| German Christopher PaulCIK 0001260835 | Officer (Corporate Controller & CAO) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | Common Stock | MOption exerciseAcquired | +1,687 | $56.69 | +$95,636.03 | 1,888 | Direct | |
| May 15, 2026 | Common Stock | MOption exerciseAcquired | +1,349 | $49.23 | +$66,411.27 | 3,237 | Direct | |
| May 15, 2026 | Common Stock | MOption exerciseAcquired | +1,406 | $17.97 | +$25,265.82 | 4,643 | Direct | |
| May 15, 2026 | Common Stock | SSaleDisposed | −4,643 | $92.21 | −$428,131.03 | 0 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| May 15, 2026 | Common Stock | MOption exerciseDisposed | −1,687 | $0.00 | $0 | 3,713 | Direct | |
| May 15, 2026 | Common Stock | MOption exerciseDisposed | −1,349 | $0.00 | $0 | 2,701 | Direct | |
| May 15, 2026 | Common Stock | MOption exerciseDisposed | −1,406 | $0.00 | $0 | 2,325 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.